These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 25265975)
21. [The assessment of the thromboembolic risk and the role of antithrombotic prophylaxis in nonrheumatic atrial fibrillation]. Fera MS; Giovannini E G Ital Cardiol; 1999 Feb; 29(2):193-213. PubMed ID: 10088078 [No Abstract] [Full Text] [Related]
23. [Clinical guidelines for antithrombotic therapy of patients with atrial fibrillation can be implemented in general practice by means of data capture]. Larsen SL; Sønderstrup D; Sønderstrup J; Toft JC Ugeskr Laeger; 2012 Sep; 174(38):2227-9. PubMed ID: 22992480 [TBL] [Abstract][Full Text] [Related]
24. eComment: Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation. Bockeria LA; Skopin II; Kuts EV Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1169. PubMed ID: 19029395 [No Abstract] [Full Text] [Related]
25. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
27. Anticoagulation in patients with valvular heart disease, atrial fibrillation, or both. Kadish SL; Lazar EJ; Frishman WH Cardiol Clin; 1987 Nov; 5(4):591-628. PubMed ID: 3331319 [TBL] [Abstract][Full Text] [Related]
28. Atrial fibrillation: food for thought in 2013. Alpert JS Am J Med; 2013 Nov; 126(11):937-8. PubMed ID: 24157284 [No Abstract] [Full Text] [Related]
29. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology]. Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786 [TBL] [Abstract][Full Text] [Related]
30. Executive summary: Prevention of thromboembolic events: the role of point of care management. J Heart Valve Dis; 2007 Mar; 16(2):184-6. PubMed ID: 17607861 [No Abstract] [Full Text] [Related]
33. eComment: Anticoagulation for mechanical heart valves: a current assessment. Koniari I Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):264-5. PubMed ID: 19164312 [No Abstract] [Full Text] [Related]
34. [Antithrombotic therapy in atrial fibrillation]. da Costa JT Acta Med Port; 1999; 12(7-11):245-54. PubMed ID: 10707462 [No Abstract] [Full Text] [Related]
35. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents. Francescone S; Halperin JL J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567 [No Abstract] [Full Text] [Related]
36. [Risks in atrial fibrillation and simultaneous renal failure]. Habich S Dtsch Med Wochenschr; 2012 Sep; 137(38):1840. PubMed ID: 23133847 [No Abstract] [Full Text] [Related]
39. [Intracardiac thrombosis and consecutive thromboembolisms in patients with heart valve diseases: predisposition and concepts for prevention]. Piper C; Horstkotte D Z Kardiol; 1998; 87 Suppl 4():1-6. PubMed ID: 9857461 [TBL] [Abstract][Full Text] [Related]